Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × Rivaroxaban × 30 days × Clear all

Sponsor

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Dexamethasone 54 Lenalidomide 35 daratumumab 34 Bortezomib 25 pomalidomide 22 Calcium Dobesilate 20 carfilzomib 19 Cyclophosphamide 19 Biopsy 18 Specimen Handling 17 Magnetic Resonance Spectroscopy 15 talquetamab 14 fludarabine 12 iberdomide 9 dexamethasone acetate 9 dexamethasone 21-phosphate 9 auricularum 9 selinexor 8 isatuximab 7 trametinib 6 fludarabine phosphate 6 tocilizumab 4 dabrafenib 4 belantamab mafodotin 4 nirogacestat 3 elotuzumab 3 X-Rays 3 Whole-Body Irradiation 3 Sunitinib 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡